Dr Tan Wu Meng

MB BChir (Cantab), MA (Cantab), PhD (Cantab), MMed (Int Med), MRCP (UK) , FAMS (Medical Oncology)

Consultant

Specialty: Medical Oncology

Sub-specialties: Breast

Conditions Treated by this Doctor:
Breast Cancer .

Clinical Appointments

Consultant Division of Medical Oncology National Cancer Centre Singapore

Profile

Dr Tan Wu Meng is Consultant, Division of Medical Oncology at the National Cancer Centre Singapore.

Wu Meng’s pre-clinical training was at Trinity College, University of Cambridge. Subsequently he was selected to join the Cambridge MBBChir-PhD scholarship programme, which combined training in clinical medicine and biomedical research. His PhD research project at the MRC Laboratory of Molecular Biology studied the molecular biology of DNA repair.

After returning to Singapore, his postgraduate medical training in Internal Medicine and Medical Oncology was at the Singapore General Hospital and National Cancer Centre Singapore. Wu Meng also worked for a time in private practice before returning to serve in the public sector.

Education

FAMS (Medical Oncology)
M.Med (Internal Medicine)
MRCP (UK)
MB BChir (Cantab)
PhD (Cantab)
BA (Hons) (Cantab)

Professional Appointments and Committee Memberships

Member, European Society of Medical Oncology (ESMO)
Fellow, Academy of Medicine, Singapore
Member, American Society of Clinical Oncology (ASCO)

Awards

Research Interests

Publications and Research Trials

Research Trials

Jain, C. Lim, E.M. Gan, D.Z. Ng, Q.S. Ng, M-K. Ang, A. Takano, K.S. Chan, W.M. Tan, R. Kanesvaran, C.K. Toh, C.M. Loo, A.A. Hsu, A. Devanand, C.H. Lim, H.N. Koong, T. Koh, K.W. Fong, S.P. Yap, S.W. Kim, B. Chowbay, L. Oon, K.H. Lim, W.T. Lim, E.H. Tan, D.S. Tan. (2015) Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. PLoS One 10(5):e0123587
W.C. Tan, A. Jain, S. Barbier, Q.S. Ng, R. Kanesvaran, M-K. Ang, A. Takano, K.H. Lim, W.M. Tan, C.K. Toh, B. Chakraborty, W-T. Lim, E.H. Tan, D.S-W. Tan. (2014) Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI). J Clin Oncol 32(suppl; abstr e19101)
W.M. Tan & D.W-T. Lim. (2014) "Chapter 10 – Nasopharyngeal Carcinoma: Distant Metastasis." Nasopharyngeal Carcinoma: Management Strategies. Ed. Sue Yom, Ed. Joseph Wee. UK: Future Medicine Ltd. ISBN: 978-1-78084-395-7
W.M. Tan, S.Y. Tan, T.M. Ng, S. Pan, R.H.H. Quek, M. Tao, D. Tai, Y.L. Koh, T.T. Tan, D.C.L. Tan, T.C. Ha, A. Chan, K. Tay, S.T. Lim. (2012) AIDS-related lymphoma (ARL) in Asians in the era of HAART and rituximab. J Clin Oncol 30(suppl; abstr e18546)
W.M. Tan, Q.S. Ng, L.T. Soh. (2011) A Missing C-Spine Link: Mind the Gap. Proceedings of Singapore Healthcare 20(1):61-3
W.M. Tan, N.L. Chlebicka, B.H. Tan. (2010) Attitudes of Patients, Visitors and Healthcare Workers at a Tertiary Hospital Towards Influenza A (H1N1) Response Measures. Annals of the Academy of Medicine, Singapore 39:303-6
W.M. Tan, M.C. Paterson, G.C. Koo, H.H. Li, A. Price, S.L.E. Loong. (2008) Increased but error-prone nonhomologous end joining in immortalized lymphoblastoid cell extracts from adult cancer patients with late radionecrosis. International Journal of Radiation Oncology, Biology, Physics 72(1):178-85
W.M. Tan, D.A. Kandiah, S.B. Tan. (2006) Hyper-Immunoglobulin E syndrome (Job Syndrome) discovered in a patient following corrective spine surgery: case report and review of the literature. Spine 31(14):E471-4
K. Sain, W.M. Tan, H. Markar. (2005) Should GP letters be copied to psychiatric outpatients? Progress in Neurology and Psychiatry 9(6):27-29
P.E. Pace, M. Johnson, W.M. Tan, G. Mosedale, C. Sng, M. Hoatlin, J. de Winter, H. Joenje, F. Gergely, K.J. Patel. (2002) FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21(13):3414-3423